Poster Session 2-30 Immune Therapy and Monitoring

[PS2-30-1] Present status and future prospects of WT1 vaccine therapy against acute myeloid leukemia

Jun Nakata¹, Yoshiki Nakae², Yo Mizutani³, Manabu Kawakami², Soyoko Morimoto⁴, Hiroko Nakajima⁵, Fumihiro Fujiki⁴, Sumiyuki Nishida⁶, Naoki Hosen⁷, Akihiro Tsuboi⁴, Yusuke Oji⁸, Yoshihiro Oka⁷, Haruo Sugiyama⁵ (1.Biomedical Infromatics, Osaka University, Osaka, Japan, 2.Hematol., Nissei Hospital, Tokyo, Japan, 3.Ikeda Municipal Hospital, Osaka, Japan, 4.Cancer Immunotherapy, Osaka University, Osaka, Japan, 5.Cancer Immunology, Osaka University, Osaka, Japan, 6.Respiratory Medicine and Clinical Immunology, Osaka University, Osaka, Japan, 7.Cancer Stem Cell Biology, Osaka University, Osaka, Japan, 8.Functional Diagnostic Science, Osaka University, Osaka, Japan)